Linda Chamberlain
Private Equity Investor chez Grand Valley State University (Michigan)
Profil
Linda Chamberlain is currently the Chief Executive Officer at nanoRETE, Inc. She is also a Director at Grand Valley State University and a Strategic Advisor at Lakewood Hughes Group LLC.
Previously, she was the Director at Michigan Accelerator Fund I LP from 2012 to 2015 and a Director at PHASIQ, Inc. Dr. Chamberlain received her doctorate degree from Purdue University in 1985.
Postes actifs de Linda Chamberlain
| Sociétés | Poste | Début |
|---|---|---|
| Grand Valley State University (Michigan) | Private Equity Investor | 01/10/2012 |
Lakewood Hughes Group LLC
 Lakewood Hughes Group LLC Investment ManagersFinance Lakewood Hughes Group LLC (Lakewood Hughes Group) is a private equity firm founded in 2020 by James V. Buzzitta and Gregory J. Corona. The firm is headquartered in Grand Rapids, Michigan. | Consultant / Advisor | - |
Anciens postes connus de Linda Chamberlain
| Sociétés | Poste | Fin |
|---|---|---|
Michigan Accelerator Fund I LP
 Michigan Accelerator Fund I LP Investment ManagersFinance Michigan Accelerator Fund I LP seeks investment opportunities in companies located in the United States, primarily in Michigan. The fund targets companies with strong intellectual properties, large market opportunities, strong management teams, clear path to profits, and scalable business models. It focuses on companies operating in the fields of life sciences technology, advanced automotive, manufacturing and materials technology, homeland security and defense technology and alternative energy technology. It provides financing for seed and early-stage capital requirements with an investment size ranging from $1 to $2 million. | Private Equity Investor | 01/04/2015 |
nanoRETE, Inc.
 nanoRETE, Inc. Medical SpecialtiesHealth Technology nanoRETE, Inc. engages in the development of a giagnostic tool. It focuses on tuberculosis screening tests. The company was founded in 2011 and is headquartered in Grand Rapids, MI. | Directeur Général | - |
PHASIQ, Inc.
 PHASIQ, Inc. Medical/Nursing ServicesHealth Services PHASIQ, Inc. provides healthcare services. It supplies immunoassay kits and custom assay development to research scientists investigating protein biomarker patterns for human health. The firm's Micropatterned Phase-Separation Technology eliminates false signals in multiplex enzyme-linked immunosorbent assay. The company was founded by Shuichi Takayama and Arlyne Simon in 2012 and is headquartered in Ann Arbor, MI. | Directeur/Membre du Conseil | - |
Formation de Linda Chamberlain
| Purdue University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
nanoRETE, Inc.
nanoRETE, Inc. Medical SpecialtiesHealth Technology nanoRETE, Inc. engages in the development of a giagnostic tool. It focuses on tuberculosis screening tests. The company was founded in 2011 and is headquartered in Grand Rapids, MI. | Health Technology |
Michigan Accelerator Fund I LP
Michigan Accelerator Fund I LP Investment ManagersFinance Michigan Accelerator Fund I LP seeks investment opportunities in companies located in the United States, primarily in Michigan. The fund targets companies with strong intellectual properties, large market opportunities, strong management teams, clear path to profits, and scalable business models. It focuses on companies operating in the fields of life sciences technology, advanced automotive, manufacturing and materials technology, homeland security and defense technology and alternative energy technology. It provides financing for seed and early-stage capital requirements with an investment size ranging from $1 to $2 million. | Finance |
PHASIQ, Inc.
PHASIQ, Inc. Medical/Nursing ServicesHealth Services PHASIQ, Inc. provides healthcare services. It supplies immunoassay kits and custom assay development to research scientists investigating protein biomarker patterns for human health. The firm's Micropatterned Phase-Separation Technology eliminates false signals in multiplex enzyme-linked immunosorbent assay. The company was founded by Shuichi Takayama and Arlyne Simon in 2012 and is headquartered in Ann Arbor, MI. | Health Services |
Lakewood Hughes Group LLC
Lakewood Hughes Group LLC Investment ManagersFinance Lakewood Hughes Group LLC (Lakewood Hughes Group) is a private equity firm founded in 2020 by James V. Buzzitta and Gregory J. Corona. The firm is headquartered in Grand Rapids, Michigan. | Finance |
